---
title: Fusion Harboring Mast Cells Can Explain Molecular Positivity in Flow Cytometric
  MRD Negative Core Binding Factor AML
date: '2024-05-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38749014/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240516181509&v=2.18.0.post9+e462414
source: Blood
description: Molecular measurable residual disease (MRD) can persist in core binding
  factor acute myeloid leukemia (AML) in otherwise disease-free patients. Utilizing
  cell sorting followed by fluorescent in situ hybridization, we show that detection
  is due to mast ...
disable_comments: true
---
Molecular measurable residual disease (MRD) can persist in core binding factor acute myeloid leukemia (AML) in otherwise disease-free patients. Utilizing cell sorting followed by fluorescent in situ hybridization, we show that detection is due to mast ...